Company Search:
Advanced Search
Sponsored Links
Ina Research Incorporation Company Snapshot
Ina Research Incorporation operates in the Biological products exc. diagnostic sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ina Research Incorporation with three other pharmaceutical manufacturers in Asia: Atect Corp (2017 sales of 2.48 billion Japanese Yen [US$22.32 million] of which 63% was Health Inspection Equipment), Pharma Foods International Co.Ltd (4.72 billion Japanese Yen [US$42.46 million] of which 73% was Functional product(Online business)), and Hester Pharmaceuticals Limited which is based in India (1.23 billion Indian Rupees [US$19.26 million] of which 88% was Poultry Vaccines).

Sales Analysis. Ina Research Incorporation reported sales of ¥2.30 billion (US$20.64 million) for the fiscal year ending March of 2017. This represents an increase of 8.5% versus 2016, when the company's sales were ¥2.12 billion. Despite this increase, sales are still well below the level achieved in 2015, when Ina Research Incorporation reported sales of ¥2.99 billion. Sales of Non-Clinical Business saw an increase that was more than double the company's growth rate: sales were up 17.2% in 2017, from ¥1.68 billion to ¥1.97 billion. Not all segments of Ina Research Incorporation experienced an increase in sales in 2017: sales of Clinical Trial Business fell 90.9% to ¥13.57 million.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Ina Research Incorporation
  Stock Performance Chart for Ina Research Incorporation
  Stock Data: Recent Stock Performance:
  Current Price (1/19/2018): 755.00
(Figures in Japanese Yen)
1 Week 2.0%   13 Weeks 5.3%  
4 Weeks 5.6%   52 Weeks 8.8%  
Ina Research Incorporation Key Data:
  Ticker: 2176 Country: Japan
  Exchanges: TYO JSQ Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Biological Products Exc. Diagnostic
  2017 Sales 2,295,919,000
(Year Ending Jan 2018).
Employees: 175
  Currency: Japanese Yen Market Cap: 2,264,094,000
  Fiscal Yr Ends: March Shares Outstanding: 2,998,800
  Share Type: Common Closely Held Shares: 1,376,800
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.